Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Tag Archives: AUTM
The AUTM CEOs Speech, Fitt 1
As part of NIST’s recent symposium on “unleashing American innovation,” the CEO of the Association of University Technology Managers (AUTM) read a talk. Let’s work through his talk and see what we can learn. I have made a transcript so … Continue reading
Guide to Bayh-Dole by the Layers, 7
Eighth layer: Outcomes We reach the eighth and final layer of Bayh-Dole: outcomes. We can consider four elements of outcomes: activity, cost, practical application, and the effects of patent monopoly exclusion on such things as research, rapid industry and professional … Continue reading
GAO reports Bayh-Dole is a do WTF you want law
Bayh-Dole is a do WTF you want law. Don’t take my word for it. You don’t even have to go read the law to see what I have been talking about. Here, check out this report from the GAO, for … Continue reading
Kill Bayh-Dole
The Bayh-Dole desperation continues. Now Bio has released its very own fakographic, citing impressive-sounding numbers with no foundation in fact, a fake history that exists in the minds of a few pundits, and perpetuates a fraud on the public that … Continue reading
Posted in Bayh-Dole
Tagged AUTM, Bayh-Dole, Bio, desperate, fakographic, pipeline, stupid policy
Comments Off on Kill Bayh-Dole
Getting at the truth about Bayh-Dole’s impact, Part 5
Now we get to the crunch of Catherine Kirby’s blog article–published at a Rice University web site for entrepreneurship–with the section “Did the Bill Work?” Since the passage of the Bayh-Dole Act, more than 5,000 new companies have formed from federally … Continue reading
The Effect of Bayh-Dole on University Therapeutics
Yesterday Kelly Sexton tweeted out the following claim: It would be great to think that the Bayh-Dole Act has resulted in a bunch of new therapeutics reaching the public. And perhaps that’s the case. And it might even be simpler … Continue reading
Posted in Bayh-Dole
Tagged AUTM, Bayh-Dole, IPA, therapeutics
Comments Off on The Effect of Bayh-Dole on University Therapeutics
PhRMA loves Bayh-Dole but won’t out and say why
PhRMA, a pharmaceutical industry lobbying group, has published a white paper championing Bayh-Dole. What they are after is to prevent the Bayh-Dole march-in provisions from ever operating. To do this, they make a variety of assertions about Bayh-Dole that can’t … Continue reading
Faux Bayh-Dole Central
The Association of University Technology Managers sponsored “Bayh-Dole Central,” (now the “Bayh-Dole History and Research Central”), a site hosted by the University of New Hampshire School of Law and devoted to the Bayh-Dole Act. There you can find all sorts … Continue reading
Vannevar Bush and the Unexpected Model of Innovation
In Science and Technology Policy in the United States: Open Systems in Action, Sylvia Kraemer spends a section of a chapter discussing Vannevar Bush and Science the Endless Frontier. Kraemer agrees that Science the Endless Frontier is an important document in … Continue reading
Posted in History, Innovation, Policy, Technology Transfer, Vannever Bush
Tagged AUTM, Benoit Godin, innovation, linear model, Sylvia Kraemer, tea, Vannevar Bush
Comments Off on Vannevar Bush and the Unexpected Model of Innovation
The $100M Rain Dance
A basic premise of university technology transfer is that research conducted at a university produces discoveries and inventions that otherwise would not be made, patents are issued on these discoveries and inventions, and the patent position induces investors and companies to … Continue reading
Posted in Bozonet, Metrics, Technology Transfer
Tagged AUTM, bustle, C4C, commercialization, Lerner, regulatory capture, startup, University of Utah, University of Washington, USTAR
Comments Off on The $100M Rain Dance